Longboard Pharmaceuticals LBPH Stock
Longboard Pharmaceuticals Price Chart
Longboard Pharmaceuticals LBPH Financial and Trading Overview
| Longboard Pharmaceuticals stock price | 19.2 USD |
| Previous Close | 7.43 USD |
| Open | 7.45 USD |
| Bid | 0 USD x 800 |
| Ask | 0 USD x 900 |
| Day's Range | 7.38 - 8.03 USD |
| 52 Week Range | 2.7 - 10.29 USD |
| Volume | 92.44K USD |
| Avg. Volume | 96.6K USD |
| Market Cap | 178.24M USD |
| Beta (5Y Monthly) | 1.234731 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.39 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 17.38 USD |
LBPH Valuation Measures
| Enterprise Value | 95.22M USD |
| Trailing P/E | N/A |
| Forward P/E | -4.240437 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 2.4705508 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -2.02 |
Trading Information
Longboard Pharmaceuticals Stock Price History
| Beta (5Y Monthly) | 1.234731 |
| 52-Week Change | 90.19% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 10.29 USD |
| 52 Week Low | 2.7 USD |
| 50-Day Moving Average | 7.59 USD |
| 200-Day Moving Average | 5.17 USD |
LBPH Share Statistics
| Avg. Volume (3 month) | 96.6K USD |
| Avg. Daily Volume (10-Days) | 85.4K USD |
| Shares Outstanding | 20.55M |
| Float | 8.93M |
| Short Ratio | 1.81 |
| % Held by Insiders | 21.06% |
| % Held by Institutions | 67.16% |
| Shares Short | 202.42K |
| Short % of Float | 1.52% |
| Short % of Shares Outstanding | 0.88% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -32.67% |
| Return on Equity (ttm) | -55.18% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -47135000 USD |
| Net Income Avi to Common (ttm) | -45804000 USD |
| Diluted EPS (ttm) | -2.6 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 76.13M USD |
| Total Cash Per Share (mrq) | 3.31 USD |
| Total Debt (mrq) | 683K USD |
| Total Debt/Equity (mrq) | 0.95 USD |
| Current Ratio (mrq) | 10.908 |
| Book Value Per Share (mrq) | 3.141 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -41135000 USD |
| Levered Free Cash Flow (ttm) | -24939500 USD |
Profile of Longboard Pharmaceuticals
| Country | United States |
| State | CA |
| City | La Jolla |
| Address | 4275 Executive Square |
| ZIP | 92037 |
| Phone | 619 592 9775 |
| Website | https://www.longboardpharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 32 |
Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel and transformative medicines for neurological diseases. Its lead product candidate is LP352, which is in Phase 1b/2a clinical trial for the treatment of seizures associated with developmental and epileptic encephalopathies. The company's preclinical product candidate includes LP659 which focuses on developing therapies for multiple neurological diseases; and LP143. It also entered into license agreement with Arena Pharmaceuticals Inc. to develop and commercialize LP352, LP659, LP143, and other compounds. The company was formerly known as Arena Neuroscience, Inc. and changed its name to Longboard Pharmaceuticals, Inc. in October 2020. Longboard Pharmaceuticals, Inc. was incorporated in 2020 and is based in La Jolla, California.
Q&A For Longboard Pharmaceuticals Stock
What is a current LBPH stock price?
Longboard Pharmaceuticals LBPH stock price today per share is 19.2 USD.
How to purchase Longboard Pharmaceuticals stock?
You can buy LBPH shares on the NasdaqGM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Longboard Pharmaceuticals?
The stock symbol or ticker of Longboard Pharmaceuticals is LBPH.
Which industry does the Longboard Pharmaceuticals company belong to?
The Longboard Pharmaceuticals industry is Biotechnology.
How many shares does Longboard Pharmaceuticals have in circulation?
The max supply of Longboard Pharmaceuticals shares is 38.87M.
What is Longboard Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
Longboard Pharmaceuticals PE Ratio is now.
What was Longboard Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
Longboard Pharmaceuticals EPS is -2.39 USD over the trailing 12 months.
Which sector does the Longboard Pharmaceuticals company belong to?
The Longboard Pharmaceuticals sector is Healthcare.
Longboard Pharmaceuticals LBPH included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ Global Market Composite NQGM | 2160.36 USD — |
-2.45
|
— — | 2147.48 USD — | 2200.33 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
- {{ link.label }} {{link}}